Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Treatment of Relapsed Leukemia After Allogeneic Bone Marrow Transplantation Using Donor-derived Lymphocytes

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00167167
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:44.408712+00:00
Published At
2017-11-29T00:00:00+00:00
Record Updated At
2017-11-29
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Leukemia, Myeloid, Chronic", "AML", "MDS", "Leukemia, Lymphocytic, Acute"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-11-29"
protocolSection.identificationModule.nctId
"NCT00167167"
protocolSection.identificationModule.officialTitle
"Treatment of Relapsed Leukemia After Allogeneic Bone Marrow Transplantation Using Donor-derived Lymphocytes"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Leukemia, Myeloid, Chronic (protocolSection.conditionsModule.conditions)
  • AML (protocolSection.conditionsModule.conditions)
  • MDS (protocolSection.conditionsModule.conditions)
  • Leukemia, Lymphocytic, Acute (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.